GLI1 and hepatocellular carcinoma: Both PTCH1 and GLI1 were observed in more than 50% of tumor tissues, and a higher ratio of GLI1 mRNA in HCC/noncancerous liver was significantly correlated with recurrence and short overall survival (OS) [36,37].